Quantbot Technologies LP Sells 23,692 Shares of Maximus, Inc. $MMS

Key Points

• Quantbot Technologies LP reduced its stake in Maximus, Inc. by 57.1%, selling 23,692 shares and holding 17,808 shares worth approximately $1.21 million at the end of the first quarter.
• Several hedge funds significantly increased their holdings in Maximus during the first quarter, with Caitong International Asset Management increasing its position by 17,533.3%.
• Maximus recently reported earnings of $2.16 EPS, exceeding estimates, and declared a quarterly dividend of $0.30 per share with a 1.4% yield.

Quantbot Technologies LP decreased its holdings in Maximus, Inc. (NYSE:MMS - Free Report) by 57.1% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 17,808 shares of the health services provider's stock after selling 23,692 shares during the quarter. Quantbot Technologies LP's holdings in Maximus were worth $1,214,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the business. Wellington Management Group LLP lifted its position in Maximus by 36.7% in the 1st quarter. Wellington Management Group LLP now owns 441,550 shares of the health services provider's stock valued at $30,109,000 after acquiring an additional 118,503 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in Maximus by 20.5% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,695,582 shares of the health services provider's stock valued at $115,620,000 after buying an additional 288,990 shares during the last quarter. Boston Partners purchased a new stake in Maximus in the 1st quarter valued at about $20,983,000. Caitong International Asset Management Co. Ltd increased its stake in Maximus by 17,533.3% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 529 shares of the health services provider's stock valued at $36,000 after buying an additional 526 shares during the last quarter. Finally, Russell Investments Group Ltd. increased its stake in Maximus by 103.5% in the 1st quarter. Russell Investments Group Ltd. now owns 79,593 shares of the health services provider's stock valued at $5,427,000 after buying an additional 40,487 shares during the last quarter. Institutional investors own 97.21% of the company's stock.

Maximus Stock Performance

Shares of MMS stock traded down $0.40 during trading hours on Thursday, hitting $87.16. 166,935 shares of the company were exchanged, compared to its average volume of 569,307. The firm has a fifty day simple moving average of $75.55 and a 200 day simple moving average of $71.38. The company has a current ratio of 2.27, a quick ratio of 2.27 and a debt-to-equity ratio of 0.91. Maximus, Inc. has a 52-week low of $63.77 and a 52-week high of $93.94. The stock has a market capitalization of $4.91 billion, a price-to-earnings ratio of 16.05 and a beta of 0.60.

Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The health services provider reported $2.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.77. The company had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.29 billion. Maximus had a net margin of 5.83% and a return on equity of 24.44%. Maximus's quarterly revenue was up 2.5% compared to the same quarter last year. During the same quarter last year, the business posted $1.74 EPS. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. Research analysts predict that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Sunday, August 31st. Investors of record on Friday, August 15th will be issued a $0.30 dividend. The ex-dividend date of this dividend is Friday, August 15th. This represents a $1.20 annualized dividend and a yield of 1.4%. Maximus's dividend payout ratio (DPR) is 22.10%.

Insider Buying and Selling

In related news, Director Gayathri Rajan sold 7,913 shares of the firm's stock in a transaction that occurred on Friday, May 30th. The shares were sold at an average price of $72.38, for a total value of $572,742.94. Following the completion of the transaction, the director directly owned 14,205 shares of the company's stock, valued at approximately $1,028,157.90. This trade represents a 35.78% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.60% of the company's stock.

Analyst Ratings Changes

Several equities research analysts have commented on MMS shares. Zacks Research upgraded shares of Maximus from a "hold" rating to a "strong-buy" rating in a research note on Tuesday. Wall Street Zen lowered shares of Maximus from a "buy" rating to a "hold" rating in a research note on Thursday, May 15th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Strong Buy" and a consensus price target of $90.00.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.